1. Kobayashi, K., & Suzuki, K. (2018). Mesenchymal stem/stromal cell-based therapy for heart failure - What is the best source? Circulation Journal, 82(9), 2222–2232.
2. Nagamura-Inoue, T., & He, H. (2014). Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility. World Journal of Stem Cells, 6(2), 195–202.
3. Arutyunyan, I., Elchaninov, A., Makarov, A., & Fatkhudinov, T. (2016). Umbilical cord as prospective source for mesenchymal stem cell-based therapy. Stem Cells International, 2016, 6901286.
4. Guan, Y. T., Xie, Y., Li, D. S., Zhu, Y. Y., Zhang, X. L., et al. (2019). Comparison of biological characteristics of mesenchymal stem cells derived from the human umbilical cord and decidua parietalis. Molecular Medicine Reports, 20(1), 633–639.
5. Wang, Q., Zhao, G., Xing, Z., Zhan, J., & Ma, J. (2019). Comparative evaluation of the osteogenic capacity of human mesenchymal stem cells from bone marrow and umbilical cord tissue. Experimental and Therapeutic Medicine, 17(1), 764–772.